Showing 1941-1950 of 3430 results for "".
Catch The Wave Of The Future
https://practicaldermatology.com/topics/practice-management/catch-the-wave-of-the-future/23478/Clearwave’s patient engagement platform may help create zero-contact offices.Data Show Impact of Dupilumab on Patients with Coexistent Atopic Diseases
https://practicaldermatology.com/topics/practice-management/data-show-impact-of-dupilumab-on-patients-with-coexistent-atopic-diseases/23477/Permanent Life Insurance, Part 2
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-part-2/23462/Who should use it and how, and who should not utilize this type of insurance.Six Dos and Don’ts of Communicating with Patients During COVID-19
https://practicaldermatology.com/topics/practice-management/six-dos-and-donts-of-communicating-with-patients-during-covid-19/23446/From patients with eczema to those considering aesthetic interventions, your audience seeks simple, predictable communication.Currents: Patient-Focused Approaches to Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-patient-focused-approaches-to-eczema/23444/Permanent Life Insurance: What It Is and Why a New Law Has Made It Better
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-what-it-is-and-why-a-new-law-has-made-it-better/23443/A review of what this insurance offers.Get The Word Out: Branding Plus Online Presence Equals Reputation Building
https://practicaldermatology.com/topics/practice-management/get-the-word-out-branding-plus-online-presence-equals-reputation-building/23441/Your online branding program and associated initiatives can improve your web ranking and your appeal to patients.DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tCaring for the Transgender Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/caring-for-the-transgender-patient/23410/Dr. Doris Day offers pearls on dermatologic care for transgender patients.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.